Showing results (251-260 of 284) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Endocrinology and Metabolism|April 13, 2010
The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)Katherine Wesseling-Perry, G Chris Harkins, He-jing Wang, et al.
Female Pelvic Medicine & Reconstructive Surgery|September 8, 2020
Patient Preferences and Knowledge Regarding Hysterectomy: A Study from the Fellows' Pelvic Research Network (FPRN)®Kristin M Jacobs, Erik D Hokenstad, Beau Y Park, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable doseMara J Horwitz, Mary Beth Tedesco, Adolfo Garcia-Ocaña, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2010
Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnoverRaquel M Carneiro, Linda Prebehalla, Mary Beth Tedesco, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 31, 2011
The effects of adiponectin and leptin on changes in bone mineral densityK E Barbour, J M Zmuda, R Boudreau, et al.
The New England Journal of Medicine|December 22, 1988
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, S Buescher, H E Broxmeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's diseaseS Jagannath, J O Armitage, K A Dicke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow supportF R Dunphy, G Spitzer, A U Buzdar, et al.
Pageof 29